You Searched For "bharat biotech s covaxin" and got 20 results
Sort By:
BHU study on Covaxin side effects poorly designed, critically flawed: ICMR Director General
The Indian Council of Medical Research Director General Dr Rajiv Bahl has criticised a recently pub…
PTI
Health Ministry rejects claim 'Covaxin was rushed due to political pressure'
The Union Health Ministry on Thursday rejected media reports that Covaxin manufacturer Bharat Biote…
Germany to recognise Bharat Biotech’s 'Covaxin' from June 1
In a tweet, Lindner said, Very happy that GER government just decided to recognize WHO-listed Covax…
DCGI gives nod to Bharat Biotech's Covaxin for 6-12 age group in India
The DGCI has asked vaccine manufacturer to submit safety data including the data on adverse event w…
DCGI grants regular market approval for Covishield, Covaxin with conditions
In a subsequent tweet, the health minister said, "The conditions include supply for programm…
Ideal time for COVID-19 booster shot is six months after the second dose, says Bharat Biotech MD
"The ideal time for a booster dose is six months after the second dose," Ella stated. Abo…
PTI
Covaxin shows 50% effectiveness against symptomatic COVID-19 in real-world assessment, says Lancet study
The results of an interim study recently published in The Lancet showed that two doses of Covaxi…
PTI
Expert committee recommends Bharat Biotech’s Covaxin for kids aged between 2-18 years
According to media reports, the Hyderabad-based Bharat Biotech had successfully completed its Ph…
Study shows booster dose of Covaxin has neutralising effect on Omicron, Delta variants, says Bharat Biotech
The study conducted at Emory University demonstrated that subjects who received a booster dose o…
PTI
WHO approves Bharat Biotech’s Covaxin for emergency use after a long wait
The WHO, in a tweet, said: "WHO has granted emergency use listing (EUL) to Covaxin, developed by…
Brazil suspends Covaxin trials, weeks after graft allegations surfaced
The termination of the pact comes after the deal with the Brazilian government for supply of 20 …
PTI
WHO may approve Bharat Biotech's Covaxin 'within 24 hours' for emergency use, according to media reports
"If all is in place and all goes well and if the committee is satisfied, we would expect a recom…
India's Covaxin 77.8% effective for COVID-19, says Lancet Report
A"The efficacy analysis demonstrates Covaxin to be 77.8 per cent effective against symptomatic…
Covaxin supply to government at ₹150 per dose is not sustainable, says Bharat Biotech
The supply price of Covaxin to the government of India at Rs 150 a dose is a non-competitive price …
Bharat Biotech’s Covaxin shows 81% efficacy after second dose in phase 3 trials
Hyderabad-based Bharat Biotech released phase 3 results of its Covid-19 vaccine — Covaxin — today. …
KTR congratulates Bharat Biotech on Covaxin approval
Hyderabad, Jan 3 (IANS) Telangana Minister for Industry and Information Technology K.T. Rama Rao on…
Nepal approves Bharat Biotech's Covaxin for emergency use
COVAXIN, which demonstrated an interim vaccine efficacy of 81 per cent in the Phase 3 clinical t…
PTI
Supreme Court wants the Indian government to explain vaccine pricing — and clarify how many doses it will need as coverage expands from May 1
The Supreme Court of India has decided it cannot be a “mute spectator” as the number of new COVID-1…
Biological E, Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses
stockpile of 50 million doses of Covaxin. Dr Vikram Paradkar, Executive Vice President (M…
PTI
Avoid Covaxin in case of allergies, fever: Bharat Biotech
Hyderabad, Jan 19 (IANS) Bharat Biotech, makers of India's first indigenous vaccine for Covid-19, h…